Evoke Neuroscience has been featured in the first-ever TransTech 200 list for advancing technology for mental and emotional wellbeing. TransTech 200, curated by the Transformative Technology Lab, is the first list to highlight pivotal innovators, influencers, organizations, scientists, and entrepreneurs who are expanding the known limits of human thriving. “We are grateful to be recognized for the work we do in the space,” said David Hagedorn, Ph.D., Evoke Neuroscience co-founder and CEO. “We are honored that our effort to bring functional neuroimaging to the physician’s office in an easy-to-use, objective, and cost-effective way is recognized as innovative and influential. Our focus is on improving human health and wellbeing, and that starts with the brain.” Awarded for innovation in the category of Neurofeedback, Evoke Neuroscience creates cutting edge technology that allows physicians to evaluate patient brain health and to train the brain in order to achieve healthier functioning. As a TransTech honoree, Evoke Neuroscience now shares a pedigree with DARPA, Google, Fitbit, HeartMath, and other notable companies and scientists on the 2016 list.
About Evoke Neuroscience
Evoke Neuroscience was formed in 2009 by research scientists, clinicians, medical doctors, and business professionals dedicated to developing and delivering the most important advances in brain science. Evoke Neuroscience’s goal is to improve people’s health, performance, and quality of life with cognitive tools that are accessible, afordable, and easy to use.
About TransTech 200 List
The TransTech 200 is the annual list of the key innovators who are driving technology for mental and emotional wellbeing forward. The list is open to both individuals and organizations who are making significant contributions via Transformative Technology research, creation, and/or distribution. Complete results of the TransTech 200 can be found at http://transtech200.com/.